---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-005176"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:22:38.519817+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Amarin appoints Murray Stewart to Board; 75% of directors new in last 12 months

## Summary
- Murray Stewart, DM FRCP, appointed to Amarin Board effective January 9, 2023.
- Stewart brings 30+ years cardiometabolic experience; formerly CMO at GSK and Rhythm Pharmaceuticals.
- Approximately 75% of independent directors are new, with six appointments over the past 12 months.
- Stewart will serve until 2023 AGM and then stand for election by shareholders.
- He will receive standard non-employee director equity awards and annual fees.

## SEC filing metadata
- accession: 0001193125-23-005176
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000119312523005176/0001193125-23-005176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000119312523005176/d443545d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-005176
- JSON: https://secwatch.observer/filing/0001193125-23-005176.json
- Plain text: https://secwatch.observer/filing/0001193125-23-005176.txt

## Key facts
- Executive change
  Murray Stewart was appointed as Director at AMARIN CORP PLCUK.
  - Action: appointed
  - Role: Director
  source text: On January 9, 2023, the Board of Directors (the “Board”) of Amarin Corporation plc (the “Company”), as part of the ongoing Board refreshment process, appointed Murray Stewart, DM, FRCP, to the Board to a term commencing immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/897448/000119312523005176/0001193125-23-005176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.